Page 36 - Flow Cytometry News Today

/PRNewswire/ -- According to the new market research report "Multiplex Assays Market by product (Consumables, Instruments, Software & Services), Type (Nucleic...

CHICAGO, Dec. 20, 2021 /PRNewswire/ -- According to the new market research report "Multiplex Assays Market by product (Consumables, Instruments, Software & Services), Type (Nucleic Acid, Protein

Researchers demonstrated the unexpected roles of nucleocapsid protein in innate and adaptive immunity to SARS-CoV-2.

A group of researchers from various institutions developed a nucleoside-modified mRNA vaccine that encodes the SARS-CoV-2 N protein (mRNA-N) and is formulated in lipid nanoparticles for this investigation (LNP).

Increased adoption of flow cytometry is an important development in the field of cell biology. Flow cytometry is a widely accepted method in detecting cancers, cell signaling, tumor characterization, fluorescent protein detection and protein-protein interaction. Moreover, flow cytometry is being increasingly used in...

Evercare Hospital Dhaka, the first JCI-accredited hospital in Bangladesh, announced at a press meet that they have successfully completed their 50th bone marrow transplant (BMT). They now have a record of conducting the highest number of allogeneic BMTs in the country.

San Jose, CA (PRWEB) December 07, 2021 -- San Jose, CA (December 7, 2021) Sony Biotechnology to hold “Virtual Summit 2021” on December 8th and 9th, 2021, on

In a recent study conducted at Yale University, USA, scientists have investigated the immunogenicity of mRNA-based coronavirus disease 2019 (COVID-19) vaccine candidates encoding the spike proteins of different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. The findings reveal that the vaccines induce robust immune responses against SARS-CoV-2 variants. The study is currently available on the bioRxiv* preprint server.

/PRNewswire/ -- In-depth analysis and data-driven insights on the impact of COVID-19 included in this global hematology testing market report. The hematology...

In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection of residual disease between three and 12 months accurately identified all patients who would eventually relapse, while other methods were less predictive.